BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34943984)

  • 21. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.
    Parwani D; Bhattacharya S; Rathore A; Mallick C; Asati V; Agarwal S; Rajoriya V; Das R; Kashaw SK
    Mini Rev Med Chem; 2021; 21(5):643-657. PubMed ID: 33138762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain.
    Jeon AB; Ackart DF; Li W; Jackson M; Melander RJ; Melander C; Abramovitch RB; Chicco AJ; Basaraba RJ; Obregón-Henao A
    Sci Rep; 2019 Feb; 9(1):1513. PubMed ID: 30728417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages.
    O'Leary S; O'Sullivan MP; Keane J
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):172-80. PubMed ID: 20889800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach.
    Ventura TL; Calixto SD; de Azevedo Abrahim-Vieira B; de Souza AM; Mello MV; Rodrigues CR; Soter de Mariz e Miranda L; Alves de Souza RO; Leal IC; Lasunskaia EB; Muzitano MF
    Molecules; 2015 May; 20(5):8072-93. PubMed ID: 25951004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents.
    Mitini-Nkhoma SC; Chimbayo ET; Mzinza DT; Mhango DV; Chirambo AP; Mandalasi C; Lakudzala AE; Tembo DL; Jambo KC; Mwandumba HC
    Front Immunol; 2021; 12():665785. PubMed ID: 34248944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.
    Moraski GC; Bristol R; Seeger N; Boshoff HI; Tsang PS; Miller MJ
    ChemMedChem; 2017 Jul; 12(14):1108-1115. PubMed ID: 28654200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Anti-Mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold.
    Nguyen TV; Minrovic BM; Melander RJ; Melander C
    ChemMedChem; 2019 May; 14(9):927-937. PubMed ID: 30834698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mycobacteriophage-derived trehalose-6,6'-dimycolate-binding peptide containing both antimycobacterial and anti-inflammatory abilities.
    Wei L; Wu J; Liu H; Yang H; Rong M; Li D; Zhang P; Han J; Lai R
    FASEB J; 2013 Aug; 27(8):3067-77. PubMed ID: 23603838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.
    Martini MC; Zhang T; Williams JT; Abramovitch RB; Weathers PJ; Shell SS
    J Ethnopharmacol; 2020 Nov; 262():113191. PubMed ID: 32730878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
    Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
    Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
    Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors.
    Christophe T; Jackson M; Jeon HK; Fenistein D; Contreras-Dominguez M; Kim J; Genovesio A; Carralot JP; Ewann F; Kim EH; Lee SY; Kang S; Seo MJ; Park EJ; Skovierová H; Pham H; Riccardi G; Nam JY; Marsollier L; Kempf M; Joly-Guillou ML; Oh T; Shin WK; No Z; Nehrbass U; Brosch R; Cole ST; Brodin P
    PLoS Pathog; 2009 Oct; 5(10):e1000645. PubMed ID: 19876393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
    Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
    BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
    Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
    PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules.
    Ackart DF; Lindsey EA; Podell BK; Melander RJ; Basaraba RJ; Melander C
    Pathog Dis; 2014 Apr; 70(3):370-8. PubMed ID: 24478046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.